Medicare Enrolled
Dr. Lauren Reager, MD
Dermatology · Santa Monica, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Reager from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reager?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Reager
Dr. Lauren Reager is a dermatology specialist in Santa Monica, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Reager performed 5,533 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Reager received a total of $3,806 from 35 pharmaceutical and/or device companies across 166 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reager is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in CA
$3,806 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,533
Medicare services
Top 22% in CA for dermatology
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,086 | $6 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
943 | $67 | $105 |
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
832 | $31 | $42 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
502 | $42 | $76 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
217 | $94 | $148 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $43 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
106 | $94 | $146 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
84 | $144 | $200 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
67 | $105 | $168 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
57 | $128 | $191 |
| Punch biopsy of additional skin growth A small circular tool is used to remove a sample of an extra skin growth for laboratory examination. |
53 | $54 | $70 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
53 | $141 | $208 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth on the body, arms, or legs that measures between 0.6 and 1.0 centimeters. |
50 | $66 | $143 |
| Shaving of skin growth, 1.1-2.0 cm This procedure involves shaving off a skin growth measuring between 1.1 and 2.0 centimeters from the body, arms, or legs. |
41 | $94 | $163 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
37 | $176 | $240 |
| Shaving of skin growth on face, 0.6-1.0 cm This procedure involves shaving off a skin growth located on the face, ears, eyelids, nose, lips, or mouth. The size of the growth being removed is between 0.6 and 1.0 centimeters. |
35 | $89 | $167 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
27 | $78 | $118 |
| Destruction of cancerous skin growth, 2.1-3.0 cm This procedure involves the removal or destruction of a cancerous skin lesion measuring between 2.1 and 3.0 centimeters located on the trunk, arms, or legs. |
26 | $135 | $224 |
| Shaving of skin growth, 0.6-1.0 cm A minor procedure to shave off a skin growth measuring 0.6 to 1.0 cm from the scalp, neck, hands, feet, or genitals. |
24 | $76 | $142 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth measuring 0.6 to 1.0 centimeters. It is performed on the scalp, neck, hands, feet, or genitals. |
20 | $121 | $185 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 20 | $135 | $209 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
17 | $84 | $125 |
| Eyelid biopsy A procedure to remove a small sample of tissue from the eyelid for laboratory examination. |
15 | $157 | $220 |
| Skin growth biopsy, first lesion A minor surgical procedure to remove a small sample of tissue from a skin growth for laboratory examination. |
13 | $126 | $185 |
| Shaving of skin growth, 1.1-2.0 cm Removal of a skin growth by shaving the surface of the skin. The procedure is performed on the face, ears, eyelids, nose, lips, or mouth and involves a lesion measuring between 1.1 and 2.0 centimeters. |
12 | $102 | $184 |
| Removal of benign skin growth from face or mouth, 0.5 cm or less This procedure involves the surgical removal of a noncancerous skin growth located on the face, ears, eyelids, nose, lips, or mouth. The growth removed is 0.5 centimeters in diameter or smaller. |
11 | $107 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$3,806
Total received (2018-2024)
Avg $544/year across 7 years
Top 33% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
166
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$640
2023
$841
2022
$988
2021
$412
2020
$239
2019
$358
2018
$328
Payments by company (2024)
ABBVIE INC.
$184
Regeneron Healthcare Solutions, Inc.
$107
Janssen Biotech, Inc.
$105
E.R. Squibb & Sons, L.L.C.
$58
SUN PHARMACEUTICAL INDUSTRIES INC.
$27
Lilly USA, LLC
$26
UCB, Inc.
$24
Kyowa Kirin, Inc.
$24
Almirall LLC
$24
Incyte Corporation
$23
Ortho Dermatologics, a division of Bausch Health US, LLC
$23
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 61.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$703
Janssen Biotech, Inc.
$441
Regeneron Healthcare Solutions, Inc.
$358
GENZYME CORPORATION
$205
Sun Pharmaceutical Industries Inc.
$174
Incyte Corporation
$157
Novartis Pharmaceuticals Corporation
$147
UCB, Inc.
$134
Lilly USA, LLC
$131
Amgen Inc.
$130
Ortho Dermatologics, a division of Bausch Health US, LLC
$130
Galderma Laboratories, L.P.
$113
PFIZER INC.
$102
Sandoz Inc.
$93
AbbVie Inc.
$89
LEO Pharma Inc.
$87
Almirall LLC
$64
MAYNE PHARMA INC.
$60
E.R. Squibb & Sons, L.L.C.
$58
Mission Pharmacal Company
$58
SUN PHARMACEUTICAL INDUSTRIES INC.
$50
Exeltis, USA Inc.
$42
EPI Health, LLC
$31
Celltrion USA Inc.
$30
SANOFI-AVENTIS U.S. LLC
$25
Kyowa Kirin, Inc.
$24
AbbVie, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$22
VYNE Pharmaceuticals Inc.
$22
Taro Pharmaceuticals USA, Inc.
$21
Aclaris Therapeutics, Inc.
$21
Celgene Corporation
$19
Merz North America, Inc.
$18
Smith+Nephew, Inc.
$13
Pierre Fabre Pharmaceuticals, Inc.
$12
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA LD · ADBRY · APEXICON E · Avar · BOTOX · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · DUOBRII · DUPIXENT · ENSTILAR · EPIDUO FORTE · EUCRISA · Ecoza · Finacea · GRAFIX PL · HUMIRA · Humira · ILUMYA · Ilumya · JUBLIA · KERYDIN · LEVULAN KERASTICK · LIBTAYO · OPZELURA · Odomzo · Otezla · Ovace · PICATO · Poteligeo · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · Seysara · Sitavig · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · XEOMIN · YUFLYMA · ZILXI
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Dermatologists in nearby ZIP areas
441
County median income
$87,760
Nearest hospital to ZIP centroid (approximate)
SANTA MONICA - UCLA MED CTR & ORTHOPAEDIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Reager is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Reager experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Reager performed 2,086 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Reager receive payments from pharmaceutical companies?
Yes. Dr. Reager received a total of $3,806 from 35 companies across 166 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reager's costs compare to other dermatologists in Santa Monica?
Dr. Reager's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reager) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatologists in Santa Monica
Browse dermatologists in Santa Monica ranked by procedure volume and transparency data.
Highest volume
Top Dermatologists in CA
Dermatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatologists in CA
Which CA dermatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology